CXCL5 and cholangiocarcinoma: The data revealed types of tumors express higher CXCL5 compared to related normal tissues, including pancreatic adenocarcinoma (PAAD), in cholangiocarcinoma (CHOL), colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), rectum adenocarcinoma (READ) and stomach adenocarcinoma (STAD) tissues.